MLN4924, a Novel Investigational Inhibitor Of NEDD8-Activating Enzyme (NAE), In Adult Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Results From Multiple Dosing Schedules In a Phase 1 Study
Year: 2013
Type: article
Study design: Clinical Trial
Source: Blood
Institutions: Dana-Farber Cancer Institute, University of Alabama at Birmingham, Colorado Blood Cancer Institute, University of Miami, Sylvester Comprehensive Cancer Center, University of Arizona, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Takeda Oncology (United States), Stanford Medicine, Stanford University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W163673794